GLP-1 Obesity or being overweight is a significant risk factor for various serious diseases
Reported Issues: Consumers report: That the supplement did not lead to weight loss or appetite suppression as advertised That the product was marketed using misleading claims about GLP-1 support That they paid for a product that did not provide the promised benefits That the supplements are promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence Experiencing adverse side effects such as stomach pain, bloating, or skin rashes Why Individuals Should Be Concerned: Potential claims include: Economic loss False advertising Safety risk Product defect Performance vs
Take This Free 3-Minute Weight Loss Sabotage Quiz Key Take-Aways for Healthy GLP-1 Management Prioritize protein and strength training Real food over processed shakes and bars Manage hydration, digestion, and mental health Weight loss is the granddaddy of goals for many of us
Florida Blue, UnitedHealthcare, Aetna, Cigna, and Humana may offer coverage depending on your plan
Within less than 2 years of being on the market, Biktarvy achieved an annual sales revenue of nearly $5 billion, setting a new record for the annual sales of a single HIV drug
Understanding GLP-1: The First Target GLP-1 became the first incretin targeted for pharmaceutical development, leading to medications like exenatide, liraglutide, and eventually semaglutide
